Oncothyreon Inc. — Form D

Oncothyreon Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2010-10-06. The offering totals $28.3M, of which $14.9M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (18)

NameRoleLocation
RICHARD L JACKSONDirectorOAK BROOK, IL
Christopher S HenneyDirectorBerkeley Heights, NJ
Ted W LoveDirectorCranbury, NJ
Scott L PetersonExecutive OfficerSeattle, WA
Gary L ChristiansonExecutive OfficerSeattle, WA
Diana L HausmanExecutive OfficerSeattle, WA
Robert L KirkmanDirectorSeattle, WA
Robert L KirkmanExecutive OfficerSeattle, WA
Julia L EastlandExecutive OfficerSeattle, WA
Daniel W SpiegelmanDirectorSeattle, WA
W. Vickery StoughtonDirectorSeattle, WA
Jay L VenkatesanExecutive OfficerSeattle, WA
Christopher L HenneyDirectorSeattle, WA
Daniel K SpiegelmanDirectorSan Francisco, CA
DOUGLAS VICKERY WILLIAMSDirectorSEATTLE, WA
JULIA MARIE EASTLANDExecutive OfficerSEATTLE, WA
Gary Vickery ChristiansonExecutive OfficerSeattle, WA
Shashi K KaranExecutive OfficerSeattle, WA

Other filings by this issuer (3)

FiledFormOfferingSold
2014-08-15D$22.9M$22.9M
2011-02-17D$150K
2010-07-15D$20.2M$200K

More